Doi.org/10.1016/S0168-8278(16)01707-4

Target Article

Efficacy and Safety of Induction Dosing of Vedolizumab for Reducing Biliary Inflammation in Primary Sclerosing Cholangitis (Psc) in Individuals with Inflammatory Bowel Disease  ; Bertus Eksteen Joan Heatherington John I Oshiomogo Remo Panaccione Gilaad Kaplan Subrata Ghosh; NULL; 09/22/2016; https://doi.org/10.1016/S0168-8278(16)01707-4

Reasons

Note: Reasons not yet here included, but you are welcome to insert this information whenever you wish.